ArticleAntibody therapeutics2026

Fully human antagonistic antibodies targeting FPR2 through dual extracellular-loop engagement for gastric cancer therapy.

Min Su Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.